gadopiclenol: Clinical Trials

4 trials of gadopiclenol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 suspended, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 2, Suspended 1, Terminated 1

Follow gadopiclenol: new trials by email Literature Review of gadopiclenol trials Research Report on gadopiclenol

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings
Gadobutrol (Gadovist/Gadavist), Gadopiclenol - Suspect Renal and Adrenal Imaging Findings
Phase 4TerminatedInsel Gruppe AG, University Hospital Bern172025-08-182026-10-16
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Elucirem (Gadopiclenol) - Myocardial Fibrosis
Phase 4RecruitingJohns Hopkins University252025-08-012026-04-13
Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)
Gadopiclenol, Gadobutrol (Gadavist, BAY86-4875) - Contrast Enhanced Images vs. Non-contrast Images, Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
Phase 4RecruitingUConn Health102025-03-252026-04-28
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Gadopiclenol - Prostate Cancer
Phase 4SuspendedColumbia University1502024-02-142026-07-20

Conditions studied

Prostatic Neoplasms (1)

Sponsors

Columbia University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Johns Hopkins University (1)  ·  UConn Health (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Andreas Christe, Prof. Dr. med. (1)  ·  Joao Lima, Professor (1)  ·  Nicolas Bloch, MD (1)